Ksenia V. Kastanenka

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease

Bence György, Camilla Lööv, Mikołaj Piotr Zaborowski et al. · Molecular Therapy — Nucleic Acids · 2018 · 177 citations · Full text

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Julien Dumurgier, Susanna Schraen, Audrey Gabelle et al. · Alzheimer s Research & Therapy · 2015 · 136 citations · Full text

Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer’s Disease

Ksenia V. Kastanenka, Steven S. Hou, Naomi Shakerdge et al. · PLoS ONE · 2017 · 107 citations · Full text

Slow Oscillation Dysfunction, Neurophysiological Biomarkers, Neurochemical Biomarkers +17

Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice

Ksenia V. Kastanenka, Thierry Bussière, Naomi Shakerdge et al. · Journal of Neuroscience · 2016 · 105 citations · Full text

Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology

Ksenia V. Kastanenka, María Calvo-Rodríguez, Steven S. Hou et al. · Scientific Reports · 2019 · 48 citations · Full text

Neurophysiological Biomarkers, Neurotransmission, Periodic Oscillations +18